Scientists at UMass Medical School have found that the Salmonella protein SipA naturally reduces a well-known drug-resistant molecule found in many different types of cancer cells. They collaborated to deploy a SipA ‘nanobug’ that rendered tumors ‘almost undetectable.’
A new NIH study published in Nature, based on research by Sharon Cantor, PhD, helps scientists better understand how hereditary breast and ovarian cancer genes function in the repair of broken DNA. Members of Dr. Cantor’s lab contributed to the study.
Job Dekker, PhD, and scientists at Institut Curie in Paris and Stanford University have taken a detailed look inside the small, densely packed structure of the inactive X chromosome found in female mammals called the Barr body.
Although Massachusetts has the lowest rate of uninsured residents nationally, those who are male, single, young, and low-income are more likely than others to be persistently uninsured, according to a new report co-authored by Michael Chin, MD, assistant professor of family medicine & community health and a health policy associate with Commonwealth Medicine.
Eighteen local teenagers who are determined to do what it takes to succeed in careers in health care are members of UMass Medical School’s High School Health Careers Program Class of 2016.
Michael Green, MD, PhD, is one of five scientific co-founders of Fulcrum Therapeutics, a new company located in Cambridge’s Kendall Square focused on discovering and developing small molecules that modulate the on/off control mechanisms that regulate genes.
GSBS student Hatem Elif Kamber Kaya was honored to have two speaking engagements at The Allied Genetics Conference, the annual national meeting of the Genetics Society of America.
Vladimir Litvak, PhD, and colleagues made a startling discovery that immune system signaling can directly affect social behavior. Published in Nature, these findings could have great implications for neurological diseases such as autism-spectrum disorders and schizophrenia.
For 20 years the Meyers Primary Care Institute—a unique partnership between UMass Medical School, Fallon Health and Reliant Medical Group—has quietly improved population health through research and education.
Third-year School of Medicine student Melanie Donahue is spending a year at the Broad Institute studying proteins with genetic mutations implicated in the development of blood cancers, thanks to a 2016 Physician-Scientist Career Development Award from the American Society of Hematology.